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Structural conservation ofcytosolic phosphoenolpyruvate carboxykinase protein and mRNA sequence was 
found in all species examined from rodents to human. The mitochondrial isoenzyme, in all species tested, 
represents a distinct protein. Moreover, irrespective of the ratio of cytosolic to mitochondrial isoenzyme, 
cytosolic phosphoenolpyruvate carboxykinase activity in the human as in the rat is controlled at the level 
of gene expression and through the same multiple hormonal stimulation. This evolutionary conservation 
of the cytosolic phosphoenolpyruvate carboxykinase structure and mode of regulation supports the en- 
zymes’ physiological importance in mammals. 
Phosphoenolpyruvate carboxykinase Gene expression 
1. INTRODUCTION 
The coexistence in tissue of isoenzymes catalyz- 
ing the same enzymatic reaction is a frequent 
phenomenon in biology, although the presence of 
one form alone may be functionally sufficient. In 
this case, isoenzymes undergo evolutionary 
changes in structure as well as in the control of 
their cellular level. Families of genes representing 
several aspects of such a divergence have been 
reported [l-5]. 
We have studied phosphoenolpyruvate carbox- 
ykinase (EC 4.1.1.32 PEPCK) which catalyzes the 
first committed gluconeogenic reaction. There are 
two PEPCK forms, one mitochondrial and the 
Abbreviations: dBcAMP, N,6-0,2-dibutyryladeno- 
sine-3 ’ 5 ’ -monophosphate; IgC, immunoglobulin; 
PEPCK, phosphoenolpyruvate carboxykinase (GTP) 
(EC 4.1.1.32); SSC, standard saline citrate; poly(A)-rich 
RNA, RNA containing poly(A) at its 3 ‘-end 
other cytosolic. Both share the same catalytic ac- 
tivity but represent distinct protein entities with no 
immune cross-reactivity between them [6-81. The 
coexistence of the two isoenzymes does not seem 
necessary since the ratio of the cytoplasmic to 
mitochondrial forms differs in various species 
[6-lo]. 
Despite the diverse representations of the two 
PEPCK forms, the crucial role of the cytosolic 
PEPCK in glucose metabolism in mammals is 
demonstrated by the fact that in most mammals 
studied it is absent in the fetus and appears in the 
liver at birth along with gluconeogenesis (review 
Benvenisty et al. [l 11). Additionally, detailed 
studies in the rat have shown that cytosolic 
PEPCK is an adaptive enzyme and the expression 
of its gene is under multiple hormonal control in a 
tissue-specific manner (review [ 11,121). Thus, 
cytosolic PEPCK provides a unique opportunity to 
examine whether its physical structure as well as 
the complex hormonal control of the expression of 
its gene are conserved, irrespective of the ratio of 
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cytosolic to mitochondrial forms in various mam- 
malian species. 
2. EXPERIMENTAL 
2.1. Animals and tissues 
Six-week-old male, sabra rats and mice (H.U. 
strains), Syrian hamsters, Psamomys obesus, 
guinea pigs and a cat (unknown age) were all from 
the Hebrew University breeding center. Chinese 
hamsters (same age) were from the Weizman In- 
stitute breeding center. Human kidney was ob- 
tained after nephrectomy. The human hepatoma 
cell line PLC/PRF/S was adapted to culture and 
maintained in RPM I medium as in [ 13,141. For 
PEPCK activity cells were washed 3 times with 
cold 0.15 M NaCl, collected with a rubber 
policeman, and frozen and thawed 3 times in 
PEPCK buffer [15]. The 100000 x g supernatant 
was taken for enzyme assay [15-171 and protein 
determination [181. 
2.2. Immunoassay of PEPCK 
Catalytic activity, immunotitration and im- 
munoprecipitation of PEPCK were performed as 
in ]15-171 and slab gel electrophoresis was accord- 
ing to Maize1 [19]. 
2.3. RNA extraction and its analysis by Northern 
and dot-blot hybridization 
Poly(A)-rich RNA was prepared as in [21,22] 
from total RNA extracted with guanidine thio- 
cyanate from livers of various mammals or from 
human kidney [20]. Total RNA from human 
hepatoma cells was similarly extracted, using a 
CsCl gradient according to Chirgwin et al. [20]. 
The RNA yield was consistently 200pg/106 cells, 
irrespective of treatment. Total RNA (20-50 pg) 
or poly(A)-rich RNA (l-10 pg) were denatured 
and size-fractionated by electrophoresis on an 
agarose gel containing 2.2 M formaldehyde [23]. 
The size of PEPCK RNA was determined from the 
migration of the markers (bacterial 16 S and 23 S 
and mammalian 28 S and 18 S ribosomal RNA). 
Total RNA from human hepatoma cells of each 
treatment was applied to nitrocellulose filters in a 
series of dots containing 3-12 pg RNA. Northern 
and dot blotting and hybridization were performed 
as in [21,22] using an EcoRI 5.4-kb fragment of 
genomic PEPCK DNA 1241 as a probe. For 
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measurements of thermal stability of hybrids, po- 
ly(A)-rich RNA from rat liver and human kidney 
was dot-blotted on nitrocellulose filters and 
hybridized with 32P-nicktranslated PEPCK cDNA 
clone (pPCK-10 [24]). After washing at room 
temperature the filters were incubated for 30 min 
in 0.1 x SSC, 0.1% SDS at various temperatures 
ranging from 50 to 80°C. The filters were then 
washed in 0.1 x SSC at room temperature. The 
radioactivity retained on the filters was quantified 
by densitometry of the autoradiographic images. 
Densitometry, using Helena Quick Scan R and D 
densitometer, of the autoradiographic images, was 
performed and the area under the peaks weighed 
yielding proportionately linearly increasing density 
with increasing amounts of RNA per dot up to 
12 pg. 
3. RESULTS AND DISCUSSION 
3.1. Structural conservation of mammalian 
cytosolic PEPCK and its mRNA 
The degree of antigenic homology of cytosolic 
PEPCK from various mammals and the size of the 
PEPCK protein were determined using rat liver 
cytosolic PEPCK antibody [ 171. Immunotitration 
of PEPCK activity in liver cytosols consistently 
resulted in a linear inactivation of PEPCK with in- 
creasing amounts of antibody, although the slopes 
obtained with several species varied considerably 
(fig.lb). Thus, identical slopes were obtained with 
PEPCK from rats, mice and hamsters, that of the 
human PEPCK deviated about 3-fold, and those 
of the fasted cat (24 h) and guinea pigs (48 h) 
deviated 4-lo-fold, respectively. In contrast, 
human mitochondrial PEPCK activity as well as 
that of the guinea pig and cat, was not neutralized 
by the antibody confirming previous results from 
rats [6], baboons [7] and chickens [8] on the 
discrete antigenic entities of the two PEPCK isoen- 
zymes. The discrete immunochemical reaction and 
the size of the cytosolic PEPCK protein were deter- 
mined from the analysis of the dissociated im- 
munoprecipitate by electrophoresis on SDS- 
polyacrylamide slab gels (fig. la). Three protein 
bands were revealed in all precipitates after stain- 
ing, two of which correspond to the antibody 
heavy and light chains and one band equal in size 
to rat cytosolic PEPCK (74000). Thus in all species 
(rats, Chinese and Syrian hamsters, guinea pigs, 
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Fig.1. (a) SDS-polyacrylamide gel electrophoresis of immune precipitated cytosolic PEPCK from vitrious mammals. 
50000 and 25000 are heavy and light chains of IgG. (a) Syrian hamster; (b) Chinese hamster; (c) fasted guinea pig; (d) 
mouse; (e) rat; (f) Psamomys obesus; (g) human; (h) rat. (b) Immunotitration of PEPCK activity from various 
mammalian species. Tissue extracts containing 40-80 munits of PEPCK catalytic activity were treated with increasing 
amounts of rat PEPCK antibody and the residual activity remaining in the supernatant determined. (A) A representative 
line of immunotitrations of cytosolic PEPCK from fasted rats, mice and Syrian and Chinese hamsters; (D) human; ( q )
fasted cat; (0) fasted guinea pig; (a) a representative line of immunotitrations of mitochondrial PEPCK (human, 
guinea pig, and a cat). 
Psu~o~y~ obesus and the human) the im- 
munoreactive PEPCK is of the same molecular size 
(fig.la). 
The homology and size of cytosolic PEPCK 
mRNA from various species was determined by 
Northern blot hybridization anaiysis of poly(A)- 
rich RNA extracted from livers (various species) 
and human kidney or cultured hepatoma cells. A 
32P-nicktranslated PEPCK genomic fragment 
(5.4 kb 1241) was used as a probe. One major 
hybridized band of a similar size (2800 bases) as 
previously determined for rat cytosolic PEPCK 
mRNA [25] was visualized in RNA from rats, 
mice, human (kidney or cultured hepatoma cells) 
and fasted guinea pig and cat (fig.2b). The 
hybridized sequences remained stable under 
relatively stringent wash conditions (0.1 x SSC at 
52’C), indicating homology of the PEPCK se- 
quences. This, together with the similarity of 
PEPCK antigenicity suggest a considerable degree 
of conservation of the primary structure of 
cytosolic PEPCK proteins in all examined species. 
Thermal stability analysis was employed to 
estimate the degree of sequence homology between 
the human and rat PEPCK mRNAs (fig.2a). 
Poly(A)-rich RNA from rat liver and human 
kidney were immobilized on nitrocellulose filters 
and hybridized with 32P-nicktranslated rat PEPCK 
cDNA, containing almost the entire coding se- 
quence [24]. The resulting melting profiles reveal 
14°C difference between the melting temperatures 
(Tm) of hybrids involving rat PEPCK mRNA (T, 
= 74°C) and those involving the human mRNA 
(Tm = 60°C). Assuming that l°C of T;, results 
from about 1.5% mismatched base-pairs 1271, the 
decreased T,,, of hybrids involving human mRNA, 
reflects about 21(r/, of sequence diversity with 
respect to the rat, and probably accounts for the 
deviated immunotitration. 
3.2. Control of cytosolic PEPCK gene expression 
The multiplicity of hormones affecting the ac- 
tivity of liver cytosolic PEPCK in the rat is a 
feature inherent to this enzyme and of great 
physiological significance to its role in 
gluconeogenesis (review [I 1,121). Detailed studies 
in the rat have shown that hormones modulate the 
activity of cytosolic PEPCK by controlling the ex- 
pression of its gene [2i,22,25,26]. The availability 
of a human hepatoma cell line in culture [ 131, 
177 
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Fig.2. (A) Thermal stability of hybrids of rat cytosolic PEPCK cDNA with PEPCK mRNA from rat and human. 4 ~8 
poly(A)-rich RNA from rat liver (m), and human kidney (e) were immobilized on nitrocellulose squares (1 cm) and 
hybridized with 32P-nicktranslated PEPCK cDNA (pPCK-10); the filters were washed as described in section 2. The 
autoradiographic images of the radioactivity retained on the filters were quantified by weighing the area under the 
densitometric peaks and plotted. Four pg of wheat germ RNA similarly immobilized served as a control for non-specific 
binding and retention of radioactivity throughout the experiment. (B) Northern blot hybridization of RNA from 
different mammalian species. Quantities, as specified, of poly(A)-rich RNA from different mammalian species were 
assayed by Northern blot hybridization as described in section 2. (a) Rat liver, 4 pg; (b) mouse kidney, 2.4 pg; (c) AKR/J 
mouse liver, 5.2 pg; (d) 48 h-fasted guinea pig liver, 8 gg; (e) 24 h-fasted cat liver, 25 gg; (f) human kidney, 1Opg. 
which retains many of the synthetic properties of 
the normal liver [ 141, provided a suitable system in 
which to examine the hormonal control of human 
PEPCK activity. The physical similarity of the 
cytosolic PEPCK and its mRNA with that of the 
rat (figs 1,2) enabled examination of the control of 
the human cytosolic PEPCK gene expression. 
Thus, in cells maintained in the absence of serum 
for 12-20 h, the addition of dBcAMP and dex- 
amethasone together, increases the activity of the 
enzyme and this effect is abolished by the concomi- 
tant addition of insulin (table 1). The abundance 
of PEPCK mRNA sequences in human cells was 
assayed by dot-blot hybridization with 32P- 
nicktranslated rat genomic DNA as a probe and 
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quantified by densitometry of the autoradio- 
graphic images. It is evident that the relative abun- 
dance of PEPCK RNA sequence is increased con- 
siderably by the inducers and that this effect is 
abolished by insulin (table 1). 
Similar results were previously found in Reuber 
H35 rat hepatoma cells from measurements of the 
rate of synthesis of PEPCK [28] and recently from 
measurements of the abundance of PEPCK 
mRNA and its synthesis [29]. Since evidence from 
the rat suggests that the cytosolic PEPCK gene is 
a unique sequence [24] it is conceivable that con- 
trol elements in the gene or in its flanking regions 
are responsible for the multiple hormonal modula- 
tions of its transcription. The direct and similar ef- 
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Table 1 REFERENCES 
Induction of cytosolic PEPCK activity and its mRNA in 
human hepatoma cells in culture and its abolishment by 
III 
insulin 
PI 
Addition to 
medium 
Cytosolic 
PEPCK 
activity 
(munit/mg 
protein) 
Abundance of 
human PEPCK 
mRNA 
Exp.A Exp.B 
(densitometric units) 
Kagamiyama, H., Sakakibara, R., Wada, H., 
Tanase, S. and Morino, Y. (1977) J. Biochem. 
(Tokyo) 82, 291-294. 
Wellman, M.L., Hoffman, W.E., Dorner, J.L. 
and Mock, R.E. (1982) Am. J. Vet. Res. 43, 
1204-1207. 
131 
141 
Serum 
None 
Inducers 
Inducers + 
9.3 42 n.d. 
7.2 8 n.d. 
15.3 105 251 
insulin 9.1 20 17 
Cells were incubated for 20 h (exp.A) and 12 h (exp.B) 
in the absence of serum with the specified additions. 
dBcAMP, 5 x 10e4 M, dexamethasone, 2 x 10e7 M 
(inducers) and insulin, 6.7 x 10m6 M (exp.A) and 6.7 x 
10m7 M (exp.B) were added where specified. Abundance 
of mRNA in human hepatoma cells was determined by 
dot-blot hybridization and expressed in arbitrary 
[51 
bl 
171 
PI 
Imumura, K. and Tanaka, T. (1982) Methods 
Enzymol. 90, 150-165. 
Schibler, U., Pittet, A.-C., Young, R.A., 
Hagenbuchle, O., Tosi, M., Gellman, S. and 
Wellauer, P.K. (1982) J. Mol. Biol. 155, 247-266. 
Battenham, P., Lovett, J.A., Starmer, W.T. and 
Sullivan, D.T. (1983) Dev. Biol. 96, 346-354. 
Ballard, F.J. and Hanson, R.W. (1969) J. Biol. 
Chem. 244, 5625-5630. 
Utter, M.F. and Chuang, D.T. (1978) Biochem. 
Sot. Trans. 6, 11-16. 
Watford, M., Hod, Y., Chiao Yu-Bin, Utter, M.F. 
and Hanson, R.W. (1981) J. Biol. Chem. 256, 
10023-10027. 
densitometric units. n.d., not determined 
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VOI 
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fects of hormones on the abundance of PEPCK 
mRNA in both the rat and human cultured 
hepatoma cells, makes it very likely that in the 
human as well, hormones modulate the activity of 
cytosolic PEPCK at the transcription level. It is 
noteworthy that this similarity in hormonal regula- 
tion is apparent despite the different proportions 
of cytosolic PEPCK in the rat (95%) and human 
cells (50%). These findings provide a suitable basis 
for identifying and studying structural elements of 
the human PEPCK gene responsive to these hor- 
mones. Conservation of the hormonal control of 
cytosolic PEPCK from rat to human is inherent to 
its physiological function. This together with the 
evolutionary conservation of its structural 
characteristics upport the enzyme’s importance to 
mammalian independent life. 
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